ARMEN GARO H 4
4 · AGENUS INC · Filed Jun 30, 2026
Research Summary
AI-generated summary of this filing
Agenus (AGEN) CEO Garo Armen Receives 5,364 Shares
What Happened
Garo H. Armen, Chairman, Chief Executive Officer and Principal Financial Officer of Agenus, received 5,364 shares of common stock on June 26, 2026. The shares were issued as salary paid in stock (an award/acquisition) at a closing price of $3.03 per share, equal to approximately $16,253. The shares were issued under the company's Amended and Restated 2019 Equity Incentive plan and were fully vested on the date of issuance.
Key Details
- Transaction date: June 26, 2026; filing date: June 30, 2026.
- Price: $3.03 per share (closing price on June 26, 2026).
- Shares acquired: 5,364; total value reported: ~$16,253.
- Shares were issued as salary in lieu of cash and are fully vested on issuance (Footnote F1).
- Shares are held in Dr. Armen’s IRA accounts (F3).
- Other disclosed holdings: 23,950 shares held by the Garo Armen 2020 2 Year AG GRAT (Dr. Armen is trustee) and 5,000 shares owned by Pixie Partners (Dr. Armen is a general partner; he disclaims beneficial ownership to the extent of his pecuniary interest) (F4).
- Filing timing: Form 4 filed June 30, 2026 — this appears to be after the typical two-business-day Form 4 filing deadline for the June 26 transaction.
Context
This transaction reflects compensation paid in stock rather than an open-market purchase or sale. Such awards are common for executive compensation and are administrative in nature; they do not necessarily indicate a change in the insider’s view of the company. The shares were fully vested at issuance and retained in retirement accounts, per the filing.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-06-26$3.03/sh+5,364$16,253→ 366,256 total
- 31,298(indirect: See Footnote)
Common Stock
[F3] - 28,950(indirect: See Footnote)
Common Stock
[F4]
Footnotes (4)
- [F1]At his request and with the approval of the Agenus Inc. Compensation Committee, Garo H. Armen's salary is being paid in stock, in lieu of cash. The amount reported herein represents the net amount of Dr. Armen's salary for the pay period ending June 26th, 2026. Such shares are issued in accordance with the Amended and Restated Agenus Inc. 2019 Equity Incentive are fully vested on the date of issuance.
- [F2]$3.03 is the closing price of our Common Stock on June 26th, 2026, the last trading day for the payroll date for the pay period ending June 26th, 2026.
- [F3]Shares are held in Dr. Armen's IRA accounts.
- [F4]Dr. Armen is trustee and has investment authority for the Garo Armen 2020 2 Year AG GRAT holder of 23,950 shares of our Common Stock. Dr. Armen is a general partner in Pixie Partners, a General Partnership ("Pixie"), which as of the date of this report owns 5,000 shares of our Common Stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Pixie and disclaims beneficial ownership to the extent of his pecuniary interest therein.